GlassScriptPrepare for your visit
Kara Deaver Chang
Wellesley, MA · NPI 1013941350
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$482.59
in general payments reported to CMS, 2019-2025 · $109 in 2025
The $109 reported for 2025 was less than what a typical provider received nationally.
Who reported paying
General payments only, top 6 by amount.
- Abbvie INC. $75.49
- Lupin INC. $63.21
- Hologic Sales and Service, LLC $48.44
- Coopersurgical, INC. $47.87
- Minerva Surgical, INC $47.43
- Astellas Pharma US INC $46.79
Drugs and devices associated with these payments
Myosure Tissue Removal Device Veozah Paragard T 380a Summit Doppler
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Kara Deaver Chang listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/137124/kara-deaver-chang